Mitochondrial Dysfunction as a Central Mechanism in Neurodegenerative Disorders
Journal of Medical Excellence · 2026-01 · 3 (1) · 50-57
DOI: 10.4103/jome.jome_25_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Excellence, online erschienen am 01.07.2026. Verfasst von Roopesh Jain. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
A BSTRACT Mitochondrial impairment underpins the pathological cascade in most major neurodegenerative diseases, including Alzheimer’s, Parkinson’s, Huntington’s, and amyotrophic lateral sclerosis. Disrupted bioenergetics, excessive reactive oxygen species, altered mitochondrial dynamics, and defects in mitophagy collectively drive neuronal loss and synaptic failure in affected brain regions. Recent advances elucidate the crosstalk between genetic, metabolic, and inflammatory signaling with mitochondrial dysfunction, opening new horizons for diagnostics and mitochondrial-targeted therapy. This review integrates molecular, clinical, and therapeutic insights, providing a robust framework for future disease modification strategies.
Zitieren
APA
Jain, R. (2026). Mitochondrial Dysfunction as a Central Mechanism in Neurodegenerative Disorders. Journal of Medical Excellence, 3(1), 50-57. https://doi.org/10.4103/jome.jome_25_25
Vancouver
Jain R. Mitochondrial Dysfunction as a Central Mechanism in Neurodegenerative Disorders. Journal of Medical Excellence. 2026;3(1):50-57. doi:10.4103/jome.jome_25_25
BibTeX
@article{Jain2026,
author = {Jain, Roopesh},
title = {Mitochondrial Dysfunction as a Central Mechanism in Neurodegenerative Disorders},
journal = {Journal of Medical Excellence},
year = {2026},
volume = {3},
number = {1},
pages = {50--57},
doi = {10.4103/jome.jome_25_25}
}
EUVIMED